Table S1. Univariate and multivariate analysis for prediction of TIM-3 expression on tumor cells in NSCLC patients.
Variables | Univariate | Multivariate | |||||
---|---|---|---|---|---|---|---|
Odds ratio | 95% CI | P | Odds ratio | 95% CI | P | ||
Age (<70 y vs. ≥70 y) | 2.667 | 0.673–10.564 | 0.163 | ||||
Sex (female vs. male) | 2.297 | 0.276–19.127 | 0.442 | ||||
Smoking status (nonsmoker vs. smoker) | 0.32 | 0.033–3.075 | 0.324 | ||||
Pathological type (non-adenocarcinoma vs. adenocarcinoma) | 1.257 | 0.299–5.290 | 0.755 | ||||
Stage (I–II vs. III–IV) | 2.713 | 0.692–10.634 | 0.152 | ||||
PD-L1 on tumor cells (negative vs. positive) | 5.318 | 1.298–21.785 | 0.02* | 5.318 | 1.298–21.785 | 0.02* | |
PD-1 on TILs (negative vs. positive) | 0.64 | 0.153–2.672 | 0.541 | ||||
PD-L1 on TILs (negative vs. positive) | 0.488 | 0.097–2.455 | 0.383 |
*, P<0.05 indicates statistical significance. NSCLC, non-small cell lung cancer; TIL, tumor infiltrating lymphocyte.